EUVIMEDEUVIMED entdecken
Crossref

The amount of sodium intake may affect the susceptibility to treatment with mineralocorticoid receptor antagonists in patients with primary aldosteronism

Satoshi Kidoguchi, Naoki Sugano, Ruri Kawauchi-Hirai, Takashi Yokoo

Clinical and Experimental Nephrology · 2026-07 · 30 (7) · 1101-1107

DOI: 10.1007/s10157-026-02874-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Nephrology, online erschienen am 13.05.2026. Verfasst von Satoshi Kidoguchi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-Ku,…. Hauptthemen laut MEDLINE: Hyperaldosteronism, Mineralocorticoid Receptor Antagonists, Sodium, Dietary, Diet, Sodium-Restricted. Die Arbeit nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Patients with primary aldosteronism (PA) have an increased risk of developing cardiovascular disease. In patients with bilateral adrenal aldosterone hypersecretion, mineralocorticoid receptor antagonists (MRAs) are recommended; however, the benefit of these agents is observed only in cases that show a sufficient increase in post-treatment PRA (responders). Because renin secretion can be influenced by sodium intake, the increase in post-treatment PRA may be attributable to sodium restriction. METHODS: A total of 90 patients who received eplerenone or esaxerenone for PA treatment were included in the study. Patients whose PRA was ≥ 1.0 ng/mL/h at one year after the initiation of MRAs treatment were defined as responders. The predictors of responders and the effect of sodium intake were investigated. RESULTS: Both baseline and post-treatment PRA and PAC levels were higher in responders. In addition, baseline estimated sodium intake tended to be lower, and post-treatment estimated sodium intake was significantly lower in responders. The post-treatment PRA value was significantly correlated with the post-treatment estimated sodium intake, and the post-treatment estimated sodium intake was an independent predictor of responders, suggesting that post-treatment PRA elevation may be partially attributable to adequate sodium restriction. However, the change in the estimated glomerular filtration rate over the 3-year follow-up period was not different between responders and non-responders. CONCLUSION: Although sodium restriction is suggested to facilitate attainment of post-treatment PRA ≥ 1.0 ng/mL/h, a marker of adequate aldosterone blockade, it remains uncertain whether achieving PRA ≥ 1.0 ng/mL/h is associated with favorable renal outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperaldosteronismMineralocorticoid Receptor AntagonistsSodium, DietaryDiet, Sodium-RestrictedHumansFemaleMaleMiddle AgedEplerenoneTreatment OutcomeAldosteroneAgedReninBiomarkersPyrrolesSulfones

Stichwörter der Autor:innen

Mineralocorticoid receptor antagonistsPrimary aldosteronismSodium intake

Substanzen

Mineralocorticoid Receptor AntagonistsEplerenoneAldosteroneesaxerenoneReninSodium, DietaryBiomarkersPyrrolesSulfones

Autor:innen und Institutionen

  • Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-Ku, Tokyo, 105-8461, Japan. s.kidoguchi@jikei.ac.jp.
  • Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-Ku, Tokyo, 105-8461, Japan.

Zitieren

APA

Kidoguchi, S., Sugano, N., Kawauchi-Hirai, R., & Yokoo, T. (2026). The amount of sodium intake may affect the susceptibility to treatment with mineralocorticoid receptor antagonists in patients with primary aldosteronism. Clinical and Experimental Nephrology, 30(7), 1101-1107. https://doi.org/10.1007/s10157-026-02874-1

Vancouver

Kidoguchi S, Sugano N, Kawauchi-Hirai R, Yokoo T. The amount of sodium intake may affect the susceptibility to treatment with mineralocorticoid receptor antagonists in patients with primary aldosteronism. Clinical and Experimental Nephrology. 2026;30(7):1101-1107. doi:10.1007/s10157-026-02874-1

BibTeX
@article{Kidoguchi2026,
  author = {Kidoguchi, Satoshi and Sugano, Naoki and Kawauchi-Hirai, Ruri and Yokoo, Takashi},
  title = {The amount of sodium intake may affect the susceptibility to treatment with mineralocorticoid receptor antagonists in patients with primary aldosteronism},
  journal = {Clinical and Experimental Nephrology},
  year = {2026},
  volume = {30},
  number = {7},
  pages = {1101--1107},
  doi = {10.1007/s10157-026-02874-1}
}
Kostenlos starten →